Earnings Call · Q4 FY2022·2023-03-06

Q4 22EPS +5.77%·Rev n/aQ3 22EPS +36.53%·Rev n/aQ2 22EPS +8.35%·Rev n/aQ1 22EPS +14.04%·Rev n/a⚠ consensus missing

Passage BIO, Inc. PASG

−2.1%1d on move date−2.1% vs SPY3d−9.0%5d−12.8%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PASG calls or request research access.

More PASG calls Browse calls Request research access